These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34176694)

  • 1. Ensuring access to high-quality substance use disorder treatment for Medicaid enrollees: A qualitative study of diverse stakeholders' perspectives.
    Zhen-Duan J; Fukuda M; DeJonckheere M; Falgas-Bagué I; Miyawaki S; Khazi P; Alegría M
    J Subst Abuse Treat; 2021 Oct; 129():108511. PubMed ID: 34176694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York.
    Alegría M; Falgas-Bague I; Fukuda M; Zhen-Duan J; Weaver C; O'Malley I; Layton T; Wallace J; Zhang L; Markle S; Neighbors C; Lincourt P; Hussain S; Manseau M; Stein BD; Rigotti N; Wakeman S; Kane M; Evins AE; McGuire T
    JAMA Health Forum; 2022 Jul; 3(7):e221771. PubMed ID: 35977217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering Barriers to Engagement in Substance Use Disorder Care for Medicaid Enrollees.
    Falgas-Bague I; Zhen-Duan J; Ferreira C; Tahanasab SA; Cuervo-Torello F; Fukuda M; Markle SL; Alegría M
    Psychiatr Serv; 2023 Nov; 74(11):1116-1122. PubMed ID: 37070259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment.
    Crable EL; Benintendi A; Jones DK; Walley AY; Hicks JM; Drainoni ML
    Implement Sci; 2022 Jan; 17(1):3. PubMed ID: 34991638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Indian and Alaska Native substance use treatment: Barriers and facilitators according to an implementation framework.
    Shukla R; Turner BJ; Ramos GG; Love M; D'Isabella J; Soto C
    J Subst Use Addict Treat; 2023 Dec; 155():209095. PubMed ID: 37277023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved access and quality of care after enrollment in the New York State Children's Health Insurance Program (SCHIP).
    Szilagyi PG; Dick AW; Klein JD; Shone LP; Zwanziger J; McInerny T
    Pediatrics; 2004 May; 113(5):e395-404. PubMed ID: 15121980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic.
    Hughes PM; Easterly CW; Thomas KC; Shea CM; Domino ME
    J Addict Med; 2024 Mar-Apr 01; 18(2):e1-e7. PubMed ID: 38345239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontline perspectives on barriers to care for patients with California Medicaid: a qualitative study.
    Faiz J; Blegen M; Nuñez V; Gonzalez D; Stokes DC; Truong K; Ryan G; Briggs-Malonson M; Kahn KL
    Int J Equity Health; 2024 May; 23(1):102. PubMed ID: 38778347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Medicaid Health Homes among people with substance use disorder and another chronic condition on health care utilization and spending: Lessons from New York State.
    Neighbors CJ; Choi S; Yerneni R; Forthal S; Morgenstern J
    J Subst Abuse Treat; 2022 Jan; 132():108503. PubMed ID: 34098212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of substance use disorder services with primary care: health center surveys and qualitative interviews.
    Urada D; Teruya C; Gelberg L; Rawson R
    Subst Abuse Treat Prev Policy; 2014 Mar; 9():15. PubMed ID: 24679108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
    Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
    Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use disorder treatment carve outs in Medicaid managed care.
    Silverman AF; Westlake MA; Hinds OM; Harris SJ; Abraham AJ; Grogan CM; Andrews CM
    J Subst Use Addict Treat; 2024 Jun; 161():209357. PubMed ID: 38554998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.
    Cummings JR; Wen H; Ko M; Druss BG
    JAMA Psychiatry; 2014 Feb; 71(2):190-6. PubMed ID: 24369387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of patients with substance use disorder before and after the Affordable Care Act.
    Campbell CI; Parthasarathy S; Altschuler A; Young-Wolff KC; Satre DD
    Drug Alcohol Depend; 2018 Dec; 193():124-130. PubMed ID: 30366189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial/Ethnic Disparities in Substance Use Treatment in Medicaid Managed Care in New York City: The Role of Plan and Geography.
    Alegría M; Falgas-Bague I; Fukuda M; Zhen-Duan J; Weaver C; O'Malley I; Layton T; Wallace J; Zhang L; Markle S; Lincourt P; Hussain S; Lewis-Fernández R; John DA; McGuire T
    Med Care; 2022 Nov; 60(11):806-812. PubMed ID: 36038524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
    Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
    BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of accountable care and payment reform on substance use disorder treatment: evidence from the initial 3 years of the alternative quality contract.
    Stuart EA; Barry CL; Donohue JM; Greenfield SF; Duckworth K; Song Z; Mechanic R; Kouri EM; Ebnesajjad C; Chernew ME; Huskamp HA
    Addiction; 2017 Jan; 112(1):124-133. PubMed ID: 27517740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators.
    O'Malley DM; Abraham CM; Lee HS; Rubinstein EB; Howard J; Hudson SV; Kieber-Emmons AM; Crabtree BF
    Fam Pract; 2022 Mar; 39(2):282-291. PubMed ID: 34423366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.